跳至主要内容
临床试验/NCT02155127
NCT02155127已完成不适用

Effects of a Walking Intervention in Older Patients With Chronic Kidney Disease: Feasibility Study

University of Utah1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2014年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
walking speed

研究概览

简要总结

Chronic kidney disease (CKD) affects more than 26 million individuals (13 percent) of the U.S. population, with a projected 70 percent increase by the year 2015 to over 40 million individuals. Impairments in physical function and mobility limitations have been reported in older Chronic Kidney Disease patients, however the consequences of impaired functioning on participation in daily life and quality of life have not been studied. Early identification and interventions to mitigate deterioration in physical function and mobility should lead to improved health and quality of life outcomes in older patients with Chronic Kidney Disease. Although older individuals with Chronic Kidney Disease have reduced survival expectancy, maintaining physical function and mobility may contribute to longer active life expectancy, and higher quality of life despite their diagnosis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male and female patients over the age of 60 years
  • •Diagnosed with moderate to severe CKD (stage 2-4)
  • •Ambulatory (with or without use of an assistive device such as a cane or walker)
  • •Living in the community, cognitively able to provide consent and understand directions for the tests
  • •Cognitive ability to understand and carry out an independent home walking program
  • •Access and ability to communicate with study staff on a weekly basis and available for follow-up testing.

排除标准

  • •Inability to carry out a program of walking independently at home
  • •Unavailable for follow-up testing, estimated GFR >60 ml/minx1.73m2 and < 15 ml/minx1.73 m2
  • •Recent cardiac event (within the past 6 months)
  • •Uncontrolled hypertension
  • •Uncontrolled diabetes
  • •Pulmonary disease that may limit the ability to progress with walking
  • •Progressive neuromuscular disease
  • •Any orthopedic or neuromuscular condition that may be exacerbated by increased walking activity
  • •diabetic foot ulcer.

研究组 & 干预措施

walking intervention

Experimental

Subjects are randomized to walking/functional strength program with weekly coaching or usual care. The program is for 12 weeks. The intervention includes 3 lower extremity strengthening exercises, and progressive walking.

干预措施: walking (Behavioral)

usual care

No Intervention

these subjects receive information on walking program, however do not receive any coaching over 12 weeks

结局指标

主要结局

walking speed

时间窗: baseline to 3 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Patricia Painter

Associate Research Faculty

University of Utah

研究点 (1)

Loading locations...

相似试验